More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply
N Engl J Med
.
2022 Mar 24;386(12):1192-1193.
doi: 10.1056/NEJMc2201556.
Epub 2022 Mar 2.
Authors
Emmanuel B Walter
1
,
Kawsar R Talaat
2
,
Alejandra Gurtman
3
Affiliations
1
Duke Human Vaccine Institute, Durham, NC.
2
Johns Hopkins University, Baltimore, MD.
3
Pfizer Vaccine Research and Development, Pearl River, NY alejandra.gurtman@pfizer.com.
PMID:
35235724
DOI:
10.1056/NEJMc2201556
No abstract available
Publication types
Letter
Comment
MeSH terms
BNT162 Vaccine*
COVID-19 Vaccines
COVID-19* / prevention & control
Child
Humans
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines
BNT162 Vaccine